Screener / SEC EDGAR /CIK 0001289848 /10-K filed Feb 24, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Industrials · Management Consulting Services

Huron Consulting Group Inc. HURN

Compare with peers Embed
The 10-K against last year's

145 changes: 7 added, 13 removed, 123 reworded, 2 quiet changes

10-K Feb 24, 2026 vs Feb 25, 2025

10-K 0001628280-26-011093 (Feb 24, 2026) vs 10-K 0001289848-25-000032 (Feb 25, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

128 paragraphs · 4 new · 38 reworded · 3 gone · 10-K Feb 24, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 69 · 42% changed Every version of it
Our engagements typically involve complex analyses and the exercise of professional judgment. As a result, we are subject to the risk of professional liability. From time to time, lawsuits with respect to our work are pending. Litigation alleging that we performed negligently or breached any other obligations could expose us to significant legal liabilities and, regardless of the outcome, is often very costly, could distract our management, could damage our reputation, and could harm our financial condition and operating results. We also face increased litigation risk as a result of an expanded workforce and should litigation arise, our potential liability may increase as our projects expand in size, breadth, and complexity. In addition, certain of our engagements, including interim management engagements and corporate restructurings, involve greater risks than other consulting engagements. We are not always able to include provisions in our engagement agreements that are designed to limit our exposure to legal claims relating to our services. While we attempt to identify and mitigate our exposure with respect to liability arising out of our consulting engagements, these efforts may be ineffective and an actual or alleged error or omission on our part or the part of our client or other third parties in one or more of our engagements could have an adverse impact on our financial condition and results of operations. In addition, we carry professional liability insurance to cover many of these types of claims, but the policy limits and the breadth of coverage may be inadequate to cover any particular claim or all claims plus the cost of legal defense. For example, we provide services on engagements in which the impact on a client may substantially exceed the limits of our professional liability insurance policy. If we are found to have professional liability with respect to work performed on such an engagement, we may not have sufficient insurance to cover the entire liability.
Paragraph 33 · 30% changed Every version of it
Specifically with respect to healthcare, many healthcare laws are complex and their application to us, our clients, or the specific services and relationships we have with our clients are not always clear. In addition, federal and state legislatures have periodically introduced programs to reform or amend the U.S. healthcare system at both the federal and state level, such as the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, and continue to consider further significant reforms. Due to the significant implementation issues arising under these laws and potential new legislation or amendments to existing legislation, it is unclear what long-term effects they will have on the healthcare industry and in turn on our business, financial condition, and results of operations. Our failure to accurately anticipate the application of new laws and regulations, or our failure to comply with such laws and regulations, could create liability for us, result in adverse publicity and negatively affect our business. Specifically with respect to healthcare, many healthcare laws are complex, and their application to us, our clients, or the specific services and relationships we have with our clients are not always clear and in turn, it is unclear what long-term effect they will have on the healthcare industry and consequently on our business, financial condition and results of operations.
Paragraph 59 · 30% changed Every version of it
As with many innovations, AI presents risks, challenges, and unintended consequences that could affect its adoption, and therefore our business. We incorporate AI solutions into some of our information platforms, products and services, and these technologies may become increasingly important to our operations over time. AI technologies are complex and rapidly evolving and the technologies that we use or develop may ultimately be flawed or we may be unable to leverage AI capabilities as quickly as the market and our clients demand. Additionally, leveraging AI capabilities to potentially improve our information platforms, products and services presents further risks and challenges. If we experience an actual or perceived breach of privacy or security incident because of the use of AI, we may lose valuable sensitive or confidential client or employee data which could damage our reputation. Further, dependence on AI without adequate safeguards to make certain business decisions may introduce additional operational vulnerabilities by impacting our relationships with customers, partners, and third-party vendors, third-parties, by producing inaccurate outcomes based on flaws in the underlying data, or other unintended results.
Paragraph 40 · 29% changed Every version of it
Our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts, and many of our client contracts are 12 months or less in duration. The volume of work performed for any particular client is likely to vary from year to year, and a major client in one fiscal period may not require or may decide not to use our services in any subsequent fiscal period. Moreover, a large portion of our new engagements come from existing clients. Accordingly, the failure to obtain new large engagements or multiple engagements from existing or new clients could have a material adverse effect on the amount of revenues we generate.
Paragraph 58 · 29% changed Every version of it
As with many innovations, AI presents risks, challenges, and unintended consequences that could affect its adoption, and therefore our business. We incorporate AI solutions into some of our information platforms, products and services, and these technologies may become increasingly important to our operations over time. AI technologies are complex and rapidly evolving and the technologies that we use or develop may ultimately be flawed or we may be unable to leverage AI capabilities as quickly as the market and our clients demand. Additionally, leveraging AI capabilities to potentially improve our information platforms, products and services presents further risks and challenges. If we experience an actual or perceived breach of privacy or security incident because of the use of AI, we may lose valuable sensitive or confidential client or employee data which could damage our reputation. Further, dependence on AI without adequate safeguards to make certain business decisions may introduce additional operational vulnerabilities by impacting our relationships with customers, partners, and third-party vendors, by producing inaccurate outcomes based on flaws in the underlying data, or other unintended results.
Paragraph 21 · 28% changed Every version of it
We have significant operations in India, including approximately 2,650 3,500 employees, which could subject the Company to country-specific risks or exacerbate certain other risks. For example, from time to time, India has experienced instances of civil unrest, terrorism and hostilities among neighboring countries. Terrorist attacks, military activity, rioting, or civil or political unrest in the future could influence the Indian economy and our operations by disrupting operations and communications and making travel within India more difficult and less desirable. Further, India has experienced natural disasters such as earthquakes, tsunamis, floods, landslides and drought in the past few years. The extent and severity of these natural disasters determines their impact on the Indian economy. Our operations and employees in India may be adversely affected by these or other social and political uncertainties or change, military activity, health-related risks, acts of terrorism or natural disasters. Additionally, as the overall population of India is large, and the cities in which we operate are dense, the impact of any such occurrences could have a disproportionate adverse effect on our operations.
Paragraph 34 · 28% changed Every version of it
There are many factors that could affect the purchasing practices, operations, and, ultimately, the operating funds of healthcare and education organizations, such as reimbursement policies for healthcare and research-related expenses, student loan policies or regulations, federal and state budgetary considerations, increased taxes, changes in the tax exempt status of healthcare and education organizations, internal stakeholders’ views of engaging third-party consultants, consolidation in either industry, and regulation, litigation, and general economic conditions. In particular, we could be required to make unplanned modifications of our products and services (which would require additional time and investment) or we could suffer reductions in demand for our products and services as a result of proposed or enacted changes in regulations affecting either industry, such as changes in the way that healthcare organizations are paid for their services (e.g., based on patient outcomes instead of services provided), changes to Medicare or Medicaid reimbursements, changes to cost rates or reimbursement rates applicable to research grants, or a decline in the level of federal or state grant spending in general. Levels of government spending are difficult to predict and subject to significant risk. Considerable uncertainty exists regarding how future budget and program decisions will unfold, including the spending priorities of the new U.S. presidential administration and Congress and what challenges budget reductions will present for the healthcare and education industries generally. Congress. Pressures on and uncertainty surrounding the U.S. federal and state governments' budgets, and potential changes in budgetary priorities and spending levels, could adversely affect the funding for individual programs and delay purchasing or payment decisions by our customers.
Paragraph 110 · 28% changed Every version of it
We may incur have incurred impairment charges with respect to our convertible debt investment in Shorelight or and our preferred stock investment in a hospital-at-home company. company, and we may incur additional impairment charges that could materially impact our results of operations.

MD&A

148 paragraphs · 3 new · 77 reworded · 10 gone · 10-K Feb 24, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 124 · 50% changed
We generate our revenues before reimbursable expenses from providing professional services and software products Our revenue is generated under the following four types of billing arrangements: fixed-fee (including software license revenue); fixed-fee; time-and-expense; performance-based; and software support, maintenance and subscriptions. Determining the method and amount of revenue to recognize requires us to make judgments and estimates.
Paragraph 138 · 46% changed
In the market approach, we utilize the guideline company method, which involves calculating EBITDA multiples based on operating data from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples are evaluated and adjusted based on specific characteristics of the reporting units relative to the selected guideline companies and applied to the reporting units' operating data to arrive at an indication of value.
Paragraph 115 · 46% changed
Borrowings outstanding under the Amended Credit Agreement at December 31, 2024 and 2023 2025 totaled $357.7 $511.0 million, consisting of $121.0 million and $324.0 million, respectively. Of the $357.7 million outstanding as of December 31, 2024, $93.0 million was outstanding under the Revolver and $264.7 $390.0 million was outstanding under the Term Loan. There were no borrowings outstanding under the Term Loan at December 31, 2023. These borrowings carried a weighted average interest rate of 4.7% at December 31, 2024 and 4.2% at December 31, 2023 including the impact of the interest rate swaps described in Note 12 “Derivative Instruments and Hedging Activity" within the notes to the consolidated financial statements.
Paragraph 83 · 43% changed
•Healthcare operating income increased $36.0 million, or 20.8%, primarily due to the increase in revenues before reimbursable expenses and a decrease in contractor expenses; partially offset by increases in compensation costs for our revenue-generating professionals, practice administration and meetings expenses, technology costs, bad debt expense, and promotion and marketing expenses. The increases in compensation costs for our revenue-generating professionals were primarily driven by an increase in headcount and annual salary increases that went into effect in the first quarter of 2024, an increase in performance bonus expense, and an increase in share-based compensation expenses; partially offset by a decrease in signing, retention and other bonus expense, and share-based compensation expense. Healthcare operating margin increased to 30.5% from 27.6% from 25.7% primarily due to the decrease decreases in contractor expenses; partially offset by an increase in salaries and related expenses for our support personnel, bad debt expense, and practice administration and meetings expenses, as a percentage of revenues before reimbursable expenses. and revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals.
Paragraph 94 · 42% changed
Adjusted EBITDA increased $33.8 million decreased $3.3 million, or 1.6%, to $201.2 $201.8 million for the year ended December 31, 2024 2025 from $167.3 $205.0 million for the year ended December 31, 2023. 2024. The increase decrease in adjusted EBITDA was primarily attributable to the increases in Healthcare and Education operating income, excluding the impact of segment depreciation and amortization and segment restructuring charges; partially offset by the increase in unallocated corporate expenses, excluding the impacts impact of the change in the market value of our deferred compensation liability liability; the pre-tax $15.0 million litigation settlement gain recognized in 2024 for a completed legal matter in which Huron was the plaintiff; the pre-tax $10.4 million of non-cash credit-related impairment charges recognized in 2025 related to our convertible debt investment in a third-party; and transaction-related expenses. the $5.0 million of non-cash impairment charges recognized on our equity investment in a hospital-at-home company in 2025. These decreases were partially offset by the increases in segment operating income for all three of our segments, excluding segment depreciation and amortization.
Paragraph 37 · 41% changed
Net •Net income increased $54.1 million, or 86.7%, to $116.6 million, or 7.7% as a percentage of total revenues, revenues was 6.2% in 2025, compared to 7.7% in 2024. Results for the year ended December 31, 2024 from $62.5 million, or 4.5% 2025 include $7.7 million of total revenues, for the same period last year. non-cash impairment charges, net of tax, related to our convertible debt investment in a third-party. Results for 2024 include an $11.1 million litigation settlement gain, net of tax, recognized in the second quarter of 2024 related to a completed legal matter in which Huron was the plaintiff. Results for 2023 include a non-cash impairment loss of $19.4 million, net of tax, related to our investment in a hospital-at-home company. As a result of the increase in net income and a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan, diluted earnings per share increased 96.6% to $6.27 for 2024, compared to $3.19 for 2023. Adjusted diluted earnings per share, which excludes the impact of the litigation settlement gain in 2024 and the non-cash impairment loss on our investment in 2023, increased 31.8% to $6.47 for 2024 from $4.91 for 2023.
Paragraph 140 · 40% changed
Pursuant to our policy, we performed our annual goodwill impairment test as of November 30, 2024 2025 for our three reporting units: Healthcare, Education, and Commercial. We elected to bypass the performed a qualitative assessment and utilized over all reporting units to determine if it was more likely than not the quantitative goodwill impairment test to provide an updated respective fair value for each values of these reporting unit as the most recent valuation quantitative analysis performed was as of January 1, 2022. units were less than their carrying amounts, including goodwill.
Paragraph 89 · 39% changed
See Note 3 “Acquisitions and Divestiture” Divestitures” within the notes to our consolidated financial statements for additional information on the divestiture completed in 2024, Note 12 “Derivative Instruments and Hedging Activity” within the notes to our consolidated financial statements for additional information on our acquisitions and foreign exchange forward contracts, Note 13 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our contingent consideration liabilities. convertible debt and equity investments, and Note 15 “Employee Benefit and Deferred Compensation Plans” within the notes to our consolidated financial statements for additional information on our deferred compensation plan.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

MD&A209 words changed in this paragraph; it is 55% similar to last year's version.
Other income (expense), net increased $32.4 totaled expense of $9.3 million for the year ended December 31, 2025, compared to income of $10.5 million for the year ended December 31, 2024 from expense 2024. In 2025, we recognized pre-tax $10.4 million of $21.9 non-cash credit-related impairment charges related to our convertible debt investment in a third-party and non-cash impairment charges of $5.0 million on our equity investment in a hospital-at-home company. These losses were partially offset by a $5.7 million gain recognized for the year ended December 31, 2023. market value of our investments that are used to fund our deferred compensation liability and $0.4 million of foreign currency transaction gains. In 2024, we recognized a $4.6 million gain for the market value of our investments that are used to fund our deferred compensation liability, a $3.6 million gain related to the divestiture of our Studer Education practice, and $2.1 million of foreign currency transaction gains. In 2023, we recognized a non-cash impairment loss of $26.3 million on our preferred stock investment in a hospital-at-home company and $0.5 million of foreign currency transaction losses, which were partially offset by a $4.8 million gain for the market value of our investments that are used to fund our deferred compensation liability. The gains recognized in 2025 and 2024 and 2023 related to the market value of our investments that are used to fund our deferred compensation liability were offset with deferred compensation expense attributable to the change in the market value of our deferred compensation liability which is recognized as a component of selling, general and administrative expenses on our consolidated statements of operations. See Note 3 "Acquisitions and Divestitures" within the notes to our consolidated financial statements for additional information on the divestiture completed in 2024, Note 13 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our preferred stock investment, and Note 15 “Employee Benefit and Deferred Compensation Plans” within the notes to our consolidated financial statements for additional information on our deferred compensation plan.

Source: Item 7, 10-K 0001628280-26-011093 vs Item 7, 10-K 0001289848-25-000032

Risk Factors142 words changed in this paragraph; it is 61% similar to last year's version.
Since 2014, we have invested $40.9 million, in the form of 1.69% convertible debt, in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight Education. Our investment is carried at its fair value of $62.3 million as of December 31, 2024, with unrealized holding gains and losses reported in other comprehensive income. income and credit-related impairment charges reported in our results of operations. As of December 31, 2024, 2025, our investment in Shorelight is in an unrealized gain position. If the investment were to be in an unrealized loss position due to significant credit deterioration with a fair value of $34.1 million, which includes the recognition of a $10.4 million credit-related impairment charge in 2025. This credit-related impairment charge was driven by the decrease in projected cash flows of Shorelight, we would recognize an allowance to decrease which reflects the carrying value of the investment to the fair value, current federal regulatory environment in which may be reversed in the event that the credit of Shorelight improves. As of December 31, 2024, we have operates. We did not recognized record any credit allowance impairment charges on our investment. convertible debt investment in 2024 and 2023. In the future, if there are additional adverse developments in Shorelight's business or the federal regulatory environment in which it operates that may be the result of events within or outside of Shorelight's control, we may incur additional impairment charges with respect to our convertible debt investment, which could materially impact our results of operations.

Source: Item 1A, 10-K 0001628280-26-011093 vs Item 1A, 10-K 0001289848-25-000032

Accounting Policies139 words changed in this paragraph; it is 39% similar to last year's version.
On March 6, 2024, September 18, 2025, the U.S. Securities FASB issued ASU 2025-06, Intangibles - Goodwill and Exchange Commission (“SEC”) adopted Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the final rule under SEC Release No. 33-11275, Accounting for Internal-Use Software, which amends the guidance in ASC 350-40, Intangibles-Goodwill and Other-Internal-Use Software. The Enhancement amendments modernize the recognition and Standardization of Climate-Related Disclosures disclosure framework for Investors, which will require registrants to disclose certain climate-related information in registration statements internal-use software costs, removing the previous “development stage” model and annual reports. The disclosure requirements introducing a more judgment-based approach. ASU 2025-06 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2025, subject to any delay which 2028, with early adoption permitted, and may result from the current administrative stay issued by the SEC. be applied prospectively, retrospectively, or via a modified prospective transition method. We expect the adoption will have no impact on our financial position or our results of operations, but we are currently evaluating the impact this guidance will have on our disclosures within our consolidated financial statements.

Source: 10-K text, Note 2 – Summary of Significant Accounting Policies, 10-K 0001628280-26-011093 vs 10-K text, Note 2 – Summary of Significant Accounting Policies, 10-K 0001289848-25-000032

Legal Proceedings17 words changed in this paragraph; it is 82% similar to last year's version.
In the second quarter of 2024, we recognized a $ 15.0 million pre-tax litigation settlement gain related to a completed legal matter in which Huron was the plaintiff, which is included in other gains, losses (gains), net on our consolidated statement of operations. As of December 31, 2024, all of the $ 15.0 million settlement was received.

Source: Item 3, via Note 18 – Commitments, Contingencies and Guarantees, 10-K 0001628280-26-011093 vs Item 3, via Note 18 – Commitments, Contingencies and Guarantees, 10-K 0001289848-25-000032

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of HURN's Risk Factors and MD&A, 10-K Feb 24, 2026 against 10-K Feb 25, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
January 1, 2022, we made, and continue to make, changes to our operating model, including how we are organized as the needs and size of our business change, and despite the operating model yielding positive synergies and impacts to date, if we do not continue to successfully refine the changes, our business and results of operations may be negatively impacted.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
Some of the uncertainty and pressures described above may increase demand for certain of our service offerings. To the extent there is more certainty or a reduction in these pressures, it may adversely affect our clients’ demand for certain of our service offerings.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedRisk Factors
In addition, changes to our service offerings or expanding current service offerings may impact our financial condition in ways that are difficult for us to predict. If we are unable to manage the risks associated with such new or expanded services offerings, or if the demand for those services declines in ways that are unanticipated our cash flows and results of operations could be adversely affected.
Read it in 10-K Feb 24, 2026 at sec.gov
RemovedRisk Factors
In addition, state tax authorities have challenged the tax-exempt status of some hospitals and other healthcare facilities claiming such status on the basis that they are operating as charitable and/or religious organizations. If the tax-exempt status of any of our clients is revoked or compromised by new legislation or interpretation of existing legislation, that client’s financial health could be adversely affected, which could adversely impact demand for our services, our sales, revenue, financial condition, and results of operations.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedRisk Factors
affect our business. Additionally, our third parties may depend on their own third-party vendors, which would be fourth parties to Huron. We generally do not have direct contact, oversight, contracts, sometimes knowledge, of these fourth parties. If a fourth party were to be breached, we would be reliant upon our third party to provide information and manage the incident.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedRisk Factors
In 2019, we invested $5.0 million, in the form of preferred stock, in a hospital-at-home company. Since our initial investment, we have recognized cumulative unrealized gains of $28.6 million and cumulative unrealized losses of $26.3 million. Our investment is carried at its fair
Read it in 10-K Feb 25, 2025 at sec.gov
RewordedRisk Factors
Specifically with respect to healthcare, many healthcare laws are complex complex, and their application to us, our clients, or the specific services and relationships we have with our clients are not always clear. clear and in turn, it is unclear what long-term effect they will have on the healthcare industry and consequently on our business, financial condition and results of operations.
Read it in 10-K Feb 24, 2026 at sec.gov
Show the other 38
RewordedRisk Factors
We have a Third Fourth Amended and Restated Security Agreement with Bank of America (the “Security Agreement”) and a Third Fourth Amended and Restated Pledge Agreement (the “Pledge Agreement”) associated with our Third Fourth Amended and Restated Credit Agreement, dated as of November 15, 2022 (as amended to date, the July 30, 2025 (the “Amended Credit Agreement”). Agreement”) with Bank of America, N.A.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
In addition, if a third-party vendor’s vendor's business changes, is reduced, fails to adapt to changing market demands, or if a third-party vendor's business or third-party technology or software that is important to our business experiences system failures, service interruptions, or security breaches, breaches or is no longer supported, it could adversely affect our business.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
As of December 31, 2024, 2025, our investment in Shorelight is in an unrealized gain position. loss position with a fair value of $34.1 million, which includes the recognition of a $10.4 million credit-related impairment charge in 2025.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
The volume of work performed for any particular client is likely to vary from year to year, and a major client in one fiscal period may not require or may decide not to use our services in any subsequent fiscal period.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
We may incur have incurred impairment charges with respect to our convertible debt investment in Shorelight or and our preferred stock investment in a hospital-at-home company. company, and we may incur additional impairment charges that could materially impact our results of operations.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
As of December 31, 2024, we have The Amended Credit Agreement established a $600 $700 million senior secured revolving credit facility (the “Revolver”) and a $275 $400 million senior secured term loan facility (the “Term Loan”), both of which fully mature on November 15, 2027. July 30, 2030.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
Our investment is carried at its fair value of $62.3 million as of December 31, 2024, with unrealized holding gains and losses reported in other comprehensive income. income and credit-related impairment charges reported in our results of operations.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
While new AI initiatives, laws, and regulations are emerging and evolving, what they ultimately will look like remains uncertain, and our obligation to comply with them proposed or enacted AI initiatives, laws, and policies regulating AI, such as the European Union's AI Act, could entail significant costs, negatively affect our business, or entirely limit our ability to incorporate certain AI capabilities into our offerings.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
If Despite the operating model yielding positive synergies and impacts to date, if we do not continue to successfully implement and refine this change to our operating model, our business and results of operation operations may be negatively impacted.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
Considerable uncertainty exists regarding how future budget and program decisions will unfold, including the spending priorities of the new U.S. presidential administration and Congress and what challenges budget reductions will present for the healthcare and education industries generally. Congress.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedRisk Factors
In the future, if there are additional adverse developments in Shorelight's business or the federal regulatory environment in which it operates that may be the result of events within or outside of Shorelight's control, we may incur additional impairment charges with respect to our convertible debt investment, which could materially impact our results of operations.
Read it in 10-K Feb 24, 2026 at sec.gov
Quiet changesRisk Factors
The healthcare and education industries are areas of significant focus for our business, and factors that adversely affect the financial condition of these industries could consequently affect our business.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
(2)The increase in the number of revenue-generating professionals within our Commercial segment includes our acquisition of Treliant in 2025. This acquisition added approximately 180 revenue-generating professionals, of which approximately 65 are consultants who work variable schedules as needed by clients.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
Borrowings outstanding under the Existing Credit Agreement at December 31, 2024 totaled $357.7 million, consisting of $93.0 million outstanding under the senior secured revolving credit facility of the Existing Credit Agreement and $264.7 million outstanding under the senior secured term loan facility of the Existing Credit Agreement.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
For our qualitative assessment, we considered the most recent quantitative analysis performed for each reporting unit, which was as of November 30, 2024, including the key assumptions used within that analysis, the indicated fair values, and the amount by which those fair values exceeded their carrying amounts. One of the key assumptions used within the prior quantitative analysis was our internal financial projections; therefore, we considered the actual performance of each reporting unit during 2025 compared to the internal financial projections used, as well as specific outlooks for each reporting unit based on our most recent internal financial projections. We also reviewed the current carrying value of each reporting unit in comparison to the carrying values as of the prior quantitative analysis. In addition, we considered various factors, including macroeconomic conditions, relevant industry and market trends for each reporting unit, and other entity-specific events, that could indicate a potential change in the fair value of our reporting units or the composition of their carrying values. Based on our assessments, we determined that it was more likely than not that the fair values for each of our reporting units exceeded their respective carrying amounts. As such, the goodwill for our reporting units was not considered impaired as of November 30, 2025, and a quantitative goodwill impairment analysis was not necessary.
Read it in 10-K Feb 24, 2026 at sec.gov
RemovedMD&A
(1)During the first quarter of 2024, we reclassified certain revenue-generating professionals within our Digital capability from our Healthcare and Education segments to our Commercial segment as these professionals are able to provide services across all of our industries. This reclassification did not impact the total Digital capability headcount for any period. The prior period headcount has been revised for consistent presentation.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
(4)During the first quarter of 2024, we reclassified one of the offerings within Education's Consulting capability to Education's Managed Services capability. This reclassification did not impact the aggregate revenues before reimbursable expenses for any period, and the prior period Education Managed Services capability revenues before reimbursable expenses and headcount in the following footnotes have been revised for consistent presentation.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
(6)During the fourth quarter of 2024, we revised the presentation of our revenue-generating professionals by capability to separately present our revenue-generating professionals in our Consulting capability from our revenue-generating professionals in our Managed Services capability. This change in presentation did not impact the headcount by capability for any period, and the prior period headcount has been revised for consistent presentation.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
On December 31, 2024, we completed the divestiture of our Studer Education practice within our Healthcare segment. This business generated revenues before reimbursable expenses of $13.7 million and $12.3 million in 2024 and 2023, respectively. The Studer Education practice was not significant to our consolidated financial statements and did not qualify as a discontinued operation for reporting under GAAP.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
and related expenses for our revenue-generating professionals; partially offset by a decrease in promotion and marketing expenses, as a percentage of revenues before reimbursable expenses.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
commitment fees and letter of credit fees will be made. These annual adjustments will not exceed an increase or decrease of 0.01% in the aggregate for all key performance indicators in the case of the commitment fee rate or an increase or decrease of 0.05% in the aggregate for all key performance indicators in the case of the Term SOFR borrowings, base rate borrowings or letter of credit fee rate.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
For each reporting unit, we reviewed goodwill for impairment by comparing the fair value of the reporting unit to its carrying value, including goodwill. In estimating the fair value of the reporting units, we relied on a combination of the income approach and the market approach, as discussed above, with a fifty-fifty weighting. Based on the results of the goodwill impairment test, we determined the fair value of the Healthcare, Education, and Commercial reporting units exceeded their carrying value by approximately 105%, 185%, and 335%, respectively. As such, we concluded that there is no indication of goodwill impairment for these three reporting units.
Read it in 10-K Feb 25, 2025 at sec.gov
RewordedMD&A
The increase decrease in net cash provided by operating activities primarily related to an increase in cash collections payments for salaries and related expenses for our revenue-generating professionals, an increase in 2024, payments for selling, general and administrative expenses, a $15 million litigation settlement received in 2024 for a completed legal matter in which Huron was the plaintiff, and a decrease in payments for contractor expenses in 2024 compared to 2023; partially offset by an increase in payments for salaries and related expenses for our revenue-generating professionals, an increase in the amount paid for annual performance bonuses in the first quarter of 2024 2025 compared to the first quarter of 2023, 2024, and an increase in payments for selling, general and administrative expenses contractor expenses; largely offset by an increase in 2024 cash collections in 2025 compared to the prior year.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
See Note 3 “Acquisitions and Divestiture” Divestitures” within the notes to our consolidated financial statements for additional information on the divestiture completed in 2024, Note 12 “Derivative Instruments and Hedging Activity” within the notes to our consolidated financial statements for additional information on our acquisitions and foreign exchange forward contracts, Note 13 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our contingent consideration liabilities. convertible debt and equity investments, and Note 15 “Employee Benefit and Deferred Compensation Plans” within the notes to our consolidated financial statements for additional information on our deferred compensation plan.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Operating expenses and operating expenses as a percentage of revenues before reimbursable expenses were as follows:Operating Expenses (in thousands, except amounts as a percentage of revenues before reimbursable expenses) Year Ended December 31, Increase / (Decrease) 2025 2024 Direct costs $ 1,122,429 67.5% $ 1,010,077 68.0% $ 112,352 Reimbursable expenses 36,301 2.2% 35,715 2.4% 586 Selling, general and administrative expenses 318,015 19.1% 286,655 19.3% 31,360 Other losses (gains), net 3,072 0.2% (14,196) (1.0)% 17,268 Restructuring charges 9,136 0.5% 9,913 0.7% (777) Depreciation and amortization 31,620 1.9% 24,822 1.7% 6,798 Total operating expenses $ 1,520,573 91.4% $ 1,352,986 91.0% $ 167,587
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
The $28.7 million increase primarily related to a $16.1 $18.5 million increase in non-payroll costs, costs was primarily driven by a $5.9 $7.3 million increase in software and data hosting expenses, a $3.3 $4.3 million increase in practice administration and meetings expenses, third-party professional fees, a $2.7 million increase in bad debt expense, and a $1.3 $2.6 million increase in promotion and marketing expenses, partially offset by a $1.3 $1.5 million decrease increase in training recruiting costs, a $1.4 million increase in business insurance costs, and a $1.2 million increase in severance expenses.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
The increase in compensation costs for our revenue-generating professionals was primarily due to the increased headcount, driven by our acquisitions of AXIA Consulting and Treliant, annual salary increases that went into effect in the first quarter of 2024 2025, and an increase increases in headcount due to the acquisition of AXIA Consulting in the fourth quarter of 2024; partially offset by decreases in performance bonus expense and signing, retention and other bonus expense and performance bonus expense for our revenue-generating professionals. expense.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
The $79.1 $99.0 million increase in compensation costs reflects our investment to grow our talented team to meet increased market demand and is primarily attributable to a $76.7 an $87.2 million increase in salaries and related expenses driven by increased headcount the recent acquisitions, hiring to support the overall increase in demand for our services, and annual salary increases that went into effect in the first quarter of 2024 and 2025, as well as a $5.5 $6.3 million increase in performance bonus expense; partially offset by expense, a $2.8 $4.4 million decrease increase in signing, retention and other bonus expense, and a $1.0 million increase in share-based compensation expense.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
The Company company has a $600 $700 million senior secured revolving credit facility (the “Revolver”) Revolver and a $275 $400 million senior secured term loan facility (the “Term Loan”), Term Loan, subject to the terms of the Third Amended and Restated Credit Agreement dated as of November 15, 2022 (as amended, the “Amended Credit Agreement”), Agreement, both of which fully mature on November 15, 2027. July 30, 2030.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Adjusted diluted earnings per share increased to $6.47 in 2024, compared to $4.91 in 2023, driven by As a result of the increase in adjusted net income and income, as well as a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan. plan, adjusted diluted earnings per share increased to $7.83 in 2025, compared to $6.47 in 2024.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
As a percentage of revenues before reimbursable expenses, direct costs decreased to 67.5% during 2025, compared to 68.0% during 2024, compared to 69.2% during 2023, primarily attributable to the decrease in contractor expenses and revenue growth that outpaced the increase in performance bonus expense for our revenue-generating professionals; partially offset by an increase in salaries and related expenses for our revenue-generating professionals, as a percentage of revenues before reimbursable expenses. professionals.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
The aggregate borrowings and repayments during 2024 2025 include the $275.0 $400 million Term Loan term loan proceeds received in the third quarter of 2025 under the Amended Credit Agreement, which were used to repay outstanding borrowings under the Revolver in the first quarter of 2024. Third Amended and Restated Credit Agreement (the “Existing Credit Agreement”).
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
To permit comparability with prior periods, we We exclude the impact of third-party advisory, legal, and accounting fees and other corporate costs incurred directly related to the evaluation and/or consummation of business acquisitions to permit comparability with prior periods as these costs are inconsistent in their amount and frequency and are significantly affected by the timing and size of our acquisitions.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Net income increased $54.1 decreased $11.6 million, or 86.7%, 9.9%, to $105.0 million, or 6.2% of total revenues, for the year ended December 31, 2025 from $116.6 million, or 7.7% of total revenues, for the year ended December 31, 2024 from $62.5 million, or 4.5% of total revenues, for the same period last year.
Read it in 10-K Feb 24, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HURN/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.